Gwladys Rivière1, Saoussen Oueslati2, Maud Gayral3, Jean-Bernard Créchet4, Naïma Nhiri1, Eric Jacquet1, Jean-Christophe Cintrat5, François Giraud1, Carine van Heijenoort1, Ewen Lescop1, Stéphanie Pethe2, Bogdan I Iorga1, Thierry Naas2, Eric Guittet1, Nelly Morellet1. 1. Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Sud, Université Paris-Saclay, LabEx LERMIT, 1 avenue de la Terrasse, 91190 Gif-sur-Yvette, France. 2. EA7361 "Structure, Dynamic, Function and Expression of Broad Spectrum β-Lactamases", Faculty of Medicine, Université Paris-Sud, Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, France. 3. Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), CNRS, Université Paris Sud, Université Paris-Saclay, 15 rue Georges Clemenceau, 91405 Orsay Cedex, France. 4. Ecole Polytechnique, Route de Saclay, F-91120 Palaiseau, France. 5. Service de Chimie Bio-organique et Marquage (SCBM), CEA, Université Paris-Saclay, LabEx LERMIT, 91191 Gif/Yvette, France.
Abstract
New Delhi metallo-β-lactamase-1 (NDM-1) has recently emerged as a global threat because of its ability to confer resistance to all common β-lactam antibiotics. Understanding the molecular basis of β-lactam hydrolysis by NDM is crucial for designing NDM inhibitors or β-lactams resistant to their hydrolysis. In this study, for the first time, NMR was used to study the influence of Zn(II) ions on the dynamic behavior of NDM-1. Our results highlighted that the binding of Zn(II) in the NDM-1 active site induced several structural and dynamic changes on active site loop 2 (ASL2) and L9 loops and on helix α2. We subsequently studied the interaction of several flavonols: morin, quercetin, and myricetin were identified as natural and specific inhibitors of NDM-1. Quercetin conjugates were also synthesized in an attempt to increase the solubility and bioavailability. Our NMR investigations on NDM-1/flavonol interactions highlighted that both Zn(II) ions and the residues of the NDM-1 ASL1, ASL2, and ASL4 loops are involved in the binding of flavonols. This is the first NMR interaction study of NDM-1/inhibitors, and the models generated using HADDOCK will be useful for the rational design of more active inhibitors, directed against NDM-1.
New Delhi metallo-β-lactamase-1 (NDM-1) has recently emerged as a global threat because of its ability to confer resistance to all common β-lactam antibiotics. Understanding the molecular basis of β-lactam hydrolysis by NDM is crucial for designing NDM inhibitors or β-lactams resistant to their hydrolysis. In this study, for the first time, NMR was used to study the influence of Zn(II) ions on the dynamic behavior of NDM-1. Our results highlighted that the binding of Zn(II) in the NDM-1 active site induced several structural and dynamic changes on active site loop 2 (ASL2) and L9 loops and on helix α2. We subsequently studied the interaction of several flavonols: morin, quercetin, and myricetin were identified as natural and specific inhibitors of NDM-1. Quercetin conjugates were also synthesized in an attempt to increase the solubility and bioavailability. Our NMR investigations on NDM-1/flavonol interactions highlighted that both Zn(II) ions and the residues of the NDM-1 ASL1, ASL2, and ASL4 loops are involved in the binding of flavonols. This is the first NMR interaction study of NDM-1/inhibitors, and the models generated using HADDOCK will be useful for the rational design of more active inhibitors, directed against NDM-1.
Gram-negative bacteria
(GNB), particularly Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter
baumannii, have reemerged as major
actors in antimicrobial resistance worldwide.[1,2] Pandrug
resistance (PDR) and multidrug resistance (MDR) have been observed
among them.[3] Currently, β-lactamase-mediated
resistance does not spare even the newest and most potent β-lactams
(carbapenems), whose activity is challenged by the class B metallo-β-lactamases
(MBLs) and by the serine-carbapenemases (classes A and D).[4−6] MBLs are by far the β-lactamases of greatest concern because
there are currently not clinically useful inhibitors for this class.[6] The spread of MBL genes among Enterobacterales
is of great clinical concern, given the importance of these pathogens
as causes of nosocomial and community-acquired infections and the
fact that MBLs inactivate expanded-spectrum cephalosporins and carbapenems,
the major antibiotics used to treat infections due to Enterobacterales.β-Lactamases catalyze the opening of the β-lactam ring,
thereby inactivating β-lactam antibiotics.[7] Based on their amino acid sequence, the β-lactamases
have been grouped into four major classes. Classes A, C, and D use
an active site serine to catalyze hydrolysis, while class B (MBLs)
requires one or two zinc ions (Zn(II)) for their activity.[8] Based on the structural diversity of the active
sites, such as differences in metal content and residues involved
in metal coordination, MBLs have been divided into three subclasses:
B1, B2, and B3.[8]The pandemic New
Delhi metallo-β-lactamase-1 (NDM-1) disseminating
worldwide in Gram-negative organisms threatens to take medicine back
into the preantibiotic era since mortality associated with infections
caused by these “superbugs” is very high and the choices
of treatment are very limited. NDM-1, a member of subclass B1 MBLs,
has rapidly spread worldwide on several MDR plasmids.[9−12] Numerous NDM-1 structures, complexed or not with metal ions and
a variety of substrates, are available in the Protein Data Bank (PDB).
NDM-1 adopts the general αβ/βα fold of MBLs,[13−18] consisting of two central β-sheets and five solvent-exposed
α-helices. Numerous experimental and theoretical studies have
been conducted to define the catalytic mechanism of NDM-1.[14,18−22] The active site is a hydrophobic cavity, which consists of two Zn(II)
(Zn1 and Zn2) surrounded by five mobile labeled loops called active
site loops (ASL1–5) responsible for substrate binding and specificity.[14] Zn1 and Zn2 are coordinated, respectively, by
H120, H122, H189 and D124, C208, H250, with different affinities,[23,24] and by a water molecule located between these two Zn(II) ions, which
acts as a nucleophile during β-lactam hydrolysis.Like
all MBLs, NDM-1 is not sensitive to any commercially available
serine-β-lactamase inhibitors. The development of chemically
active inhibitors for the NDM-1 enzyme has been extensively undertaken.[17,25−46] The metal chelator edetate disodium (EDTA) has also been shown to
inactivate the enzymatic activity of NDM-1 by removing the catalytically
required Zn(II) ions,[17,47] but its toxicity impedes its
clinical use. Potent inhibitors of NDM-1 have also been identified
through virtual screening of natural compounds, such as the natural
product aspergillomaramine, analogous to the metal-ion chelator EDTA,[48,49] baicalin,[50] and magnolol, which has a
significant impact on NDM-1 enzyme activity in vitro,[51] and hesperidin, which acts directly on key residues near
the active site of NDM-1.[52]To better
understand the impact of Zn(II) on the structural and
dynamic behavior of NDM-1, we analyzed this protein in the presence
and absence of Zn(II) by NMR. We showed that not only loops carrying
the zinc ligands undergo a significant change in their dynamic behavior
but also other regions far from the active site. In addition, we identified
three flavonols: morin, quercetin, and myricetin as specific inhibitors
of NDM-1 activity. Flavonols are naturally occurring polyphenolic
compounds that are ubiquitous in a wide range of vascular plants.[53] They are a class of flavonoids that are recognized
to have a variety of biological activities and important therapeutic
applications.[54−62] We used NMR spectroscopy to map the site of interaction on NDM-1
during complexation to the three flavonols. Our results show that
the NDM-1 loops, ASL1, ASL2, and ASL4 are perturbated by flavonol
binding and that Zn(II) ions are involved in their binding. Our NMR
data provide support for the NDM-1/flavonol complex models, generated
using the HADDOCK program, which will be useful for the rational design
of ligands with increased activity.
Results and Discussion
NDM-1
Is Stabilized in the Presence of Zn(II)
We verified
by NMR spectroscopy and thermal shift experiments that NDM-1 was produced
without Zn(II). The addition of EDTA did not induce any chemical shift
variation in the heteronuclear single quantum correlation (HSQC) spectra
and did not modify the thermostability profiles of NDM-1 (data not
shown). The addition of increasing amounts of Zn(II) to the metal-free
NDM-1, followed by thermal shift assay resulted in an increase in
the denaturation temperature of the protein (Figure and Supporting Information Table S1), indicating that Zn(II) strongly stabilizes NDM-1.
However, at a high concentration of Zn(II), we observed a notable
increase in fluorescence background prior to denaturation of NDM-1,
suggesting the appearance of an exposed hydrophobic region or the
formation of oligomers. This effect occurred at a Zn(II) concentration
greater than 2 molar equiv relative to the protein concentration and
increased sharply with increasing Zn(II) concentration. It could be
explained by intermolecular interactions between several NDM-1 proteins,
mediated by His-tag/Zn(II) complexes.
Figure 1
Effect of Zn(II) ions on the denaturation
of NDM-1 followed by
thermal shift assay. Thermal denaturation profiles of NDM-1 were studied
in the presence of various concentrations of ZnCl2 (0–50
μM) and 9 μM of NDM-1.
Effect of Zn(II) ions on the denaturation
of NDM-1 followed by
thermal shift assay. Thermal denaturation profiles of NDM-1 were studied
in the presence of various concentrations of ZnCl2 (0–50
μM) and 9 μM of NDM-1.The effect of Zn(II) binding on the structural and dynamic properties
of NDM-1 was investigated by NMR. The 1H–15N HSQC spectra of 15N-labeled NDM-1, recorded in the absence
and presence of 2 molar equiv of Zn(II), showed well-dispersed cross-peaks
characteristic of a well-folded protein (Figure a).
Figure 2
(a) Superimposition of the 1H–15N
HSQC spectra recorded in the absence of Zn(II) (black) and in the
presence of 2 molar equiv of Zn(II) (red). (b) Superimposition of
the 1H–15N HSQC spectra recorded on NDM-1
in the absence of Zn(II) (dark blue) and in the presence of 1 (cyan)
and 2 molar equiv of Zn(II) (red). Zoomed-in images corresponding
to the boxes (1) and (2) highlighted in (a).
(a) Superimposition of the 1H–15N
HSQC spectra recorded in the absence of Zn(II) (black) and in the
presence of 2 molar equiv of Zn(II) (red). (b) Superimposition of
the 1H–15N HSQC spectra recorded on NDM-1
in the absence of Zn(II) (dark blue) and in the presence of 1 (cyan)
and 2 molar equiv of Zn(II) (red). Zoomed-in images corresponding
to the boxes (1) and (2) highlighted in (a).In the presence of 1 Zn(II) equivalent, we observed a slow exchange,
on the NMR chemical shift timescale, between the metal-free and the
di-Zn(II) states of NDM-1 (Figure b), in agreement with the high affinity of NDM-1 for
Zn(II).[23,24] Upon the addition of 2 molar equiv of Zn(II),
we only observed resonances of the NDM-1 bound state, demonstrating
that NDM-1 binds two Zn(II) ions, in accordance with the crystal structures
of NDM-1. The 1H–15N HSQC spectrum underwent
a drastic change that affected the majority of cross-peaks (Figure a), as already mentioned
by Zheng et al.[63] Above 2 Zn(II) equivalents,
a dramatic decrease of all of the 1H–15N cross-peak intensities was observed (Supporting Information Figure S1) as well as heavy precipitation, suggesting
the formation of insoluble NDM-1 oligomers. These NMR data are in
agreement with thermal shift experiments (Figure ), which show that a slight excess of Zn(II)
induces NDM-1 oligomerization. Therefore, to limit protein self-association
for the rest of this study, we decided to never exceed the 2 molar
equiv of Zn(II).
NMR Backbone Resonance Assignment of NDM-1
To determine
the NDM-1 residues most heavily influenced by Zn(II) binding, we assigned
the backbone NMR resonances of NDM-1 alone and complexed with Zn(II),
using the classical triple resonance and nuclear Overhauser effect
spectroscopy (NOESY) correlation experiments. The optimal quality
of the spectra, used for assignment, was observed at 20 °C in
the absence of Zn(II) (Supporting Information Figures S2 and S3) and at 27 °C in the presence of 150
mM NaCl and 2 molar equiv of Zn(II) relative to the NDM-1 concentration
(Supporting Information Figures S4 and S5). A total of 226 of the 253 metal-free NDM-1 backbone amide protons
were assigned. Missing assignments are those of unstructured N-terminus
residues (M28-E30) and residues in flexible loops (e.g., V118-D130,
Q151-V155, G207, and C208) (Supporting Information Figure S6a). From the di-Zn(II)NDM-1 sample, 94% of the 1H–15N cross-peaks were assigned. Only backbone
proton assignments of 14 residues (residues M28-E30, N57, K125, M126,
G186, G207, K216, N220, L221, A257, L271, and E272) were missing,
probably due to the conformational exchange or fast exchange with
the solvent, which resulted in a significant broadening for these
amino acids. Many of these residues play an important role in the
enzymatic catalysis. Indeed, the residues N220 and L221 are located
in the ASL4 loop, which plays a direct role in substrate recognition.[64] Additional 10% backbone resonances have been
assigned over the available assignment of NDM-1 in the presence of
Zn(II)[65] (Supporting Information Figure S6b).Substantial differences were
observed between the 1H–15N HSQC spectra
recorded on metal-free NDM-1 and di-Zn(II)NDM-1 (Supporting Information Figures S2 and S4). Analysis of the 15N–1H chemical shift differences after the addition
of increasing concentration of Zn(II) to NDM-1 suggests that the protein
undergoes local structural changes upon binding to Zn(II) (Figure a). Since the resonances
of the ASL2 and L9 loops and of the helix α2 could not be observed
in the absence of Zn(II), no information could be obtained on the
chemical shift variations for these three domains in the presence
of Zn(II). The largest observable variations are in the ASL3 and ASL5
loops, which include the H189, C208, and H250 residues involved in
the coordination of the two Zn(II). It is interesting to note that
domains remote from the Zn(II) binding site, such as the β-sheet,
which flanks the ASL1 loop and the L5 and L9 loops (Figure b), are also affected by the
Zn(II) binding. On the contrary, the ASL1 and ASL4 loops show only
a minor chemical shift variation upon Zn(II) binding, with the exception
of the first residues of the ASL4 loop (residues 206–209),
probably due to the coordination of C208 with Zn(II).
Figure 3
Specific interactions
between NDM-1 and Zn(II). (a) Chemical shift
variations of the nitrogen and amide proton nuclei between metal-free
NDM-1 and di-Zn(II) NDM-1. The 1H and 15N chemical
shifts were extracted from NDM-1 spectra recorded at 25 °C and
600 MHz 1H frequency in the absence of Zn(II), on a sample
containing 50 mM phosphate buffer (pH 7.0 and 150 mM NaCl), in the
presence of 2 molar equiv of Zn(II) on a solution sample containing
0.1 mM bis tris (pH 7.0, 150 mM NaCl) (Δδ (1H, 15N) = [((ΔδH)2 + (ΔδN)2 × 0.14) × 0.5]1/2). In red and orange
are indicated the residues with Δδ > 0.4 ppm and 0.2
>
Δδ > 0.4 ppm, respectively. The unassigned residues
of
NDM-1 in the absence and presence of Zn(II) are represented by dark
blue and green lines, respectively. (b) Location of the residues whose
amide proton and nitrogen resonances are significantly disturbed during
Zn(II) binding, mapped on the NDM-1 crystal structure (PDB: 3SPU) with the same color
code. Zn(II) are represented by green spheres.
Specific interactions
between NDM-1 and Zn(II). (a) Chemical shift
variations of the nitrogen and amide proton nuclei between metal-free
NDM-1 and di-Zn(II)NDM-1. The 1H and 15N chemical
shifts were extracted from NDM-1 spectra recorded at 25 °C and
600 MHz 1H frequency in the absence of Zn(II), on a sample
containing 50 mM phosphate buffer (pH 7.0 and 150 mM NaCl), in the
presence of 2 molar equiv of Zn(II) on a solution sample containing
0.1 mM bis tris (pH 7.0, 150 mM NaCl) (Δδ (1H, 15N) = [((ΔδH)2 + (ΔδN)2 × 0.14) × 0.5]1/2). In red and orange
are indicated the residues with Δδ > 0.4 ppm and 0.2
>
Δδ > 0.4 ppm, respectively. The unassigned residues
of
NDM-1 in the absence and presence of Zn(II) are represented by dark
blue and green lines, respectively. (b) Location of the residues whose
amide proton and nitrogen resonances are significantly disturbed during
Zn(II) binding, mapped on the NDM-1 crystal structure (PDB: 3SPU) with the same color
code. Zn(II) are represented by green spheres.The location of the secondary structure elements in the metal-free
NDM-1 and di-Zn(II)NDM-1 complex derived from TALOS–N software[66] was in very good agreement with that of the
NDM-1 crystal structures in the absence and presence of Zn(II)[13,67] (Supporting Information Figure S6). The
results also show that the binding of Zn(II) ions does not significantly
modify the NDM-1 secondary structures.
Analysis of NDM-1 Dynamics
by NMR
To better understand
the impact of Zn(II) binding on the dynamics of NDM-1, we collected 15N R1 and R2 relaxation rates and 1H–15N
heteronuclear NOE (hetNOE) values that provide information on the
local and global dynamics in the protein. The results show that the
overall structure of NDM-1 is rigid in the presence or absence of
Zn(II), with the exception of the N-terminal extremity, which has
shorter transversal relaxation rates and lower hetNOE values, indicating
greater flexibility in the 100 ps timescale (Supporting Information Figure S7). The 15N relaxation rates
are homogeneous over the folded domains with mean values of R1 and R2 of 0.73
± 0.08 and 24.22 ± 1.69 s–1, respectively,
in the absence of Zn(II), and 0.64 ± 0.05 and 31.19 ± 1.27
s–1, respectively, in the presence of Zn(II) (Supporting
Information Table S2). The lower mean value
of R1 and the higher mean value of R2 calculated in the presence of Zn(II) could
be explained by the NDM-1 intermolecular interactions induced by a
slight excess of Zn(II), as already seen in the thermal shift experiments.
In addition, the relaxation data show that only the ASL1 loop (residues
65–74) is slightly more flexible than the rigid zones of the
protein in both the absence and presence of Zn(II) (for additional
information, see Table S2 and Figure S7).The main effects of the binding of the two Zn(II) occurred
at the loops ASL2 and L9, and at α2 helix. In the absence of
zinc, the residues belonging to these domains showed disappearance
of their signals, consistent with an intermediate exchange at the
NMR chemical shift timescale, whereas in the presence of zinc, the
signals of these residues are perfectly visible and the measured relaxation
parameters for these three domains indicate their significant stiffening
(Supporting Information Table S2). Indeed,
in the absence of Zn(II), the three Zn(II) ligands (H120, H122, and
D124) belonging to the ASL2 loop undergo fluctuations that propagate
through the ASL2 loop and α2 helix. The ASL2 and L9 loops could
influence each other due to their spatial proximities in the three-dimensional
(3D) structure (Figure a). The same effects of Zn(II) were observed by Chen et al. using
molecular dynamics (MD) simulations.[22] In
addition, the authors also showed that the di-Zn(II) coordination
exerts stronger restrictions on the movements of ASL1 and ASL4 loops
(denoted L3 and L10, respectively, in Chen et al.[22]). Our relaxation data did not indicate a decrease in the
internal flexibility of ASL1 and ASL4 upon Zn(II) binding contrary
to that observed in their MD simulations.[22]
Figure 4
(a)
Superimposition on the backbone atoms for the domain 45–270
of four metal-free apo-NDM-1 (PDB: 3RKK, 3SBL, 3RKJ, 3PG4) and (b) four apo-NDM-1 (PDB: 3SPU, 4TYF, 4TZE, 4TZF) crystallographic
structures. Highly flexible domains, far from the active site, are
colored purple, and flexible domains bearing Zn(II) ligands are colored
light blue and dark blue. The residues interacting directly with Zn(II)
are represented by stick, and the residues interacting with Zn1 and
in Zn2 are in pink and orange, respectively. Both Zn(II) are represented
by white spheres.
(a)
Superimposition on the backbone atoms for the domain 45–270
of four metal-free apo-NDM-1 (PDB: 3RKK, 3SBL, 3RKJ, 3PG4) and (b) four apo-NDM-1 (PDB: 3SPU, 4TYF, 4TZE, 4TZF) crystallographic
structures. Highly flexible domains, far from the active site, are
colored purple, and flexible domains bearing Zn(II) ligands are colored
light blue and dark blue. The residues interacting directly with Zn(II)
are represented by stick, and the residues interacting with Zn1 and
in Zn2 are in pink and orange, respectively. Both Zn(II) are represented
by white spheres.Our results are consistent
with crystallographic structures that
show that in the absence of zinc, the variabilities in the orientation
of ligands that can bind to Zn1 and Zn2 are higher for Zn1 (H120,
H122, and H189) than for Zn2 (D124, C208, and H250) (Figure a). These observations are
validated by comparing the B-factors of several NDM-1 structures crystallized
in the absence and presence of Zn(II). B-factors can be used to identify
and interpret the dynamic characteristics of proteins.[68] Furthermore, the flexibilities of ASL1 observed
by NMR for di-Zn(II)NDM-1 (Figure b) are in agreement with that observed by comparison
of several X-ray crystal structures of di-Zn(II)NDM-1, which show
only significant differences in the orientations of the ASL1 loop
(Figure b). These
observations are also consistent with the results showing that the
loop ASL1 is a key loop capable of correctly orienting the substrate
in the active site and should therefore, due to its flexibility, be
able to adapt to many types of ligands.[13,14,67,69,70]
Flavonol Molecules Inhibit NDM-1 Activity
NDM-1 uses
two Zn(II) ions and a water molecule coordinated in between in its
active site, for the hydrolysis of the antibiotics β-lactam
ring.[8] Based on this mechanism, we sought
to determine the inhibitory activity of simplified structures, providing
an initial structure–activity relationship (SAR) that highlighted
a common fragment, which was a phenol, substituted with a keto moiety
in the position 2 (Figure a). The second ketone substituent may be aromatic, enolic,
or aliphatic, the best inhibitory activities being obtained in the
first two cases. On the basis of this minimal structure, a chemoinformatic
analysis identified 222 molecules of this type available within the
LabEx LERMIT chemical library (Figure ). Biological screening of this library using the miniaturized
automated assay allowed us to identify three flavonols (quercetin,
myricetin, and morin) as the best inhibitors of NDM-1 (Figure b). Overall, the best results
have been obtained for myricetin (85% of inhibition at 50 μM).
The IC50 for myricetin was determined as 3.3 μM (Figure c).
Figure 5
(a) Summary of the inhibitory
activity of commercially available
hydroxyketone derivatives. (b) All of these molecules have the general
structure of the flavonoids, a 15-carbon skeleton, which consists
of the two phenyl rings A and B and the heterocyclic ring C. Quercetin,
myricetin, morin, and rutin differ from each other in the number and
position of the hydroxy groups: quercetin, myricetin, and morin. In
rutin, the hydroxy group at position C-3 is substituted by glucose
and rhamnose sugar groups. The potential chelation sites of Zn(II)
are surrounded by red rectangles. Eriodictyiol, taxifolin, naringenin,
and dihydromyricetin have two stereocenters on the C-ring, unlike
the previous ones which have none. They also differ from each other
in the number and position of hydroxy groups. (c) IC50 determination
for myricetin on purified NDM-1. Representation of the IC50 curve for myricetin with the residual activity of NDM-1 monitored
by hydrolysis of different concentrations of inhibitor with a constant
concentration of imipenem (100 μM). (d) Quercetin derivatives
have been synthesized and tested as inhibitors of NDM-1, with methylation
on the 3′ (MG187c), 3 (MG194c2), or 5 (MG188c) hydroxy group,
oxime formation on the 4-carbonyl group of naringenin (MG219F3), and
the addition of isopropyl carbonate or methyl isopropyl carbonate
on the 3′ hydroxy group (MG195c).
(a) Summary of the inhibitory
activity of commercially available
hydroxyketone derivatives. (b) All of these molecules have the general
structure of the flavonoids, a 15-carbon skeleton, which consists
of the two phenyl rings A and B and the heterocyclic ring C. Quercetin,
myricetin, morin, and rutin differ from each other in the number and
position of the hydroxy groups: quercetin, myricetin, and morin. In
rutin, the hydroxy group at position C-3 is substituted by glucose
and rhamnose sugar groups. The potential chelation sites of Zn(II)
are surrounded by red rectangles. Eriodictyiol, taxifolin, naringenin,
and dihydromyricetin have two stereocenters on the C-ring, unlike
the previous ones which have none. They also differ from each other
in the number and position of hydroxy groups. (c) IC50 determination
for myricetin on purified NDM-1. Representation of the IC50 curve for myricetin with the residual activity of NDM-1 monitored
by hydrolysis of different concentrations of inhibitor with a constant
concentration of imipenem (100 μM). (d) Quercetin derivatives
have been synthesized and tested as inhibitors of NDM-1, with methylation
on the 3′ (MG187c), 3 (MG194c2), or 5 (MG188c) hydroxy group,
oxime formation on the 4-carbonyl group of naringenin (MG219F3), and
the addition of isopropyl carbonate or methyl isopropyl carbonate
on the 3′ hydroxy group (MG195c).Due to solubility problems, IC50 values for quercetin
could only be estimated between 5 and 10 μM. To solve this solubility
problem, derivatives of quercetin were synthesized (Figure d, Supporting Information Figures S8–S10, and Supporting Information Experimental Section on the chemical synthesis
of the compounds) that were expected to have improved solubility or
bioavailability. Unfortunately, their inhibitory activities were not
very different from that observed for quercetin (Figure d). Only the mixture of quercetin
derivatives with the addition of isopropyl carbonate or methyl isopropyl
carbonate to the 3′ hydroxy group (MG195c) has a higher inhibitory
activity than quercetin and also higher than that observed with myricetin
(Figure d). On the
other hand, oxime formation on the 4-carbonyl group of naringenin
(MG219F3) induced a slight decrease in the inhibitory activity of
this compound (Figure b,d). On the basis of these results, it appears that: the 4-carbonyl
group is important for the activities of the molecules; the possible
steric gene induced by OMe in position 3′, 5, or 3 has little
effect on their activities; and the addition of polar compounds such
as isopropyl carbonate or methyl isopropyl carbonate to hydroxy group
3 increases the activity of the quercetin derivative. None of the
quercetin derivatives produced better result than myricetin. Myricetin
was also tested at a concentration of 50 μM against other carbapenemases:
OXA-48 and KPC-2, with inhibitions of 90 and 78%, respectively.
In Vivo Activities of Flavonol Molecules on Clinical NDM-1 Producing Escherichia coli and Klebsiella pneumoniae Isolates
Minimum inhibitory concentrations (MICs) of imipenem
for K. pneumoniae CAG andE. coli GUE expressing NDM-1 were determined in the
presence of increasing amounts of myricetin (Table ) to assess in vivo activity on bacteria.
Height-fold drop in MICs was observed with 500 μM myricetin
(decreasing from 128 to 16 μg/mL) for K. pneumoniae CAG, and a 16-fold drop in MICs for E coli GUE with 500 μM myricetin (from 128 to 8 μg/mL), illustrating
that these molecules have an in vivo activity. A concentration of
500 μM myricetin has no effect on the growth of the bacteria
in the absence of imipenem. The values for quercetin could not be
determined accurately, due to solubility problems. Nevertheless, at
100 and 200 μM, two and three dilution drops of MICs were observed
with the E. coli GUE NDM-1 strain,
respectively. No effect was observed with the strain K. pneumoniae CAG (Table ). From our inhibitor activity assay data,
we identified the flavonols as candidate inhibitors of the NDM-1 activity.
The flavonols are abundant in various fruits and vegetables and are
known to interact with proteins involved in cancer, as well as cardiovascular
and brain diseases.[54−62,71,72]
Table 1
Minimum Inhibitory Concentrations
of Imipenem in the Presence of Myricetin and Quercetin for E. coli GUE NDM-1 and K. pneumoniae CAG NDM-1
myricetin
quercetin
concentration
(μM)
0
50
100
0
100
200
MICs (μg/mL)
E. coli NDM-1 GUE
128
32
8
128
32
16
K. pneumonia NDM-1
CAG
128
64
16
128
128
128
NMR Characterization of the Binding Interface
between NDM-1
and the Three Flavonols: Morin, Myricetin, and Quercetin
The NDM-1/flavonol interactions were investigated by NMR in the presence
of Zn(II) (Figure ). As the ligands (morin, myricetin, and quercetin) were poorly soluble
in aqueous solution (these molecules are hydrophobic, and the Log P
estimate indicated that myricetin had the best solubility in aqueous
buffer (Supporting Information Table S3)), they were introduced into the NDM-1 samples from a concentrated
stock of a deuterated dimethyl sulfoxide (DMSO). The addition of small
amounts of DMSO did not cause precipitation of the protein or chemical
shift variations (Figure a). The interaction of NDM-1 with the three flavonols resulted
in significant chemical shift perturbations (CSPs) of many backbone
amide protons and nitrogens. Representative extracts of 1H–15N HSQC spectra along the titration are shown
in Figure b, and the 1H–15N chemical shift perturbations after
the addition of 2 molar equiv of inhibitors are shown in Figure . The analysis highlighted
a specific site for interaction of the three flavonols with NDM-1.
The NDM-1 residues involved in the interaction with the three flavonols
belong mainly to the flexible loops ASL1, ASL2, and ASL4, and to a
lesser extent to ASL3 and L5 (Figure ) with subtle differences between the three flavonols.
The residues in the ASL1 and ASL4 loops have the highest CSPs in the
presence of morin, and W93 and H250 have much higher CSP in the presence
of morin (Figure a3)
than in the presence of quercetin (Figure a1) or myricetin
(Figure a2).
Figure 6
Specific interaction
between NDM-1 and flavonols. Selected regions
of the 1H–15N HSQC spectra probing the
NDM-1–flavonol interactions. (a) Addition of DMSO (black in
the absence of DMSO and pink in the presence of the amount of DMSO
corresponding to that added to have 2 molar equiv of flavonol relative
to the concentration of NDM-1: 5.36 μL of DMSO) does not induce
significant chemical shift variations of the NDM-1 resonances. (b)
Titrations of NDM-1 (black in the absence of flavonol) by 1 molar
equiv (in blue) and 2 molar equiv (in red) of morin (b1), quercetin
(b2), and myricetin (b3) showing the influence of flavonols on several
NDM-1 resonances. The spectra were recorded in the presence of 2 molar
equiv of Zn(II).
Figure 7
(a) Plots of the measured
chemical shift perturbations of the amide
protons and nitrogens of NDM-1, in the presence of 2 molar equiv of
Zn(II), after addition of 2 molar equiv of flavonols: (a1) quercetin,
(a2) myricetin, and (a3) morin. (b) Plots of the measured chemical
shift perturbations of the amide protons and nitrogens of NDM-1, in
the absence of Zn(II) and 2 molar equiv of morin (b1) and 4 molar
equiv of morin (b2). In red, orange, and yellow are represented the
residues with Δδ > 0.09 ppm, 0.09 > Δδ
> 0.05
ppm, and Δδ > 0.02 ppm, respectively. The unassigned
residues
of NDM-1 are represented by gray lines.
Specific interaction
between NDM-1 and flavonols. Selected regions
of the 1H–15N HSQC spectra probing the
NDM-1–flavonol interactions. (a) Addition of DMSO (black in
the absence of DMSO and pink in the presence of the amount of DMSO
corresponding to that added to have 2 molar equiv of flavonol relative
to the concentration of NDM-1: 5.36 μL of DMSO) does not induce
significant chemical shift variations of the NDM-1 resonances. (b)
Titrations of NDM-1 (black in the absence of flavonol) by 1 molar
equiv (in blue) and 2 molar equiv (in red) of morin (b1), quercetin
(b2), and myricetin (b3) showing the influence of flavonols on several
NDM-1 resonances. The spectra were recorded in the presence of 2 molar
equiv of Zn(II).(a) Plots of the measured
chemical shift perturbations of the amide
protons and nitrogens of NDM-1, in the presence of 2 molar equiv of
Zn(II), after addition of 2 molar equiv of flavonols: (a1) quercetin,
(a2) myricetin, and (a3) morin. (b) Plots of the measured chemical
shift perturbations of the amide protons and nitrogens of NDM-1, in
the absence of Zn(II) and 2 molar equiv of morin (b1) and 4 molar
equiv of morin (b2). In red, orange, and yellow are represented the
residues with Δδ > 0.09 ppm, 0.09 > Δδ
> 0.05
ppm, and Δδ > 0.02 ppm, respectively. The unassigned
residues
of NDM-1 are represented by gray lines.On the contrary, the highest CSPs were observed in the ASL2 loop
in the presence of quercetin compared to those observed after the
addition of morin. Although specific, the flavonol binding induced
CSPs over relatively large regions of the flexible domains such as
62–80, 208–223, and 250–254 (Figure a). CSPs were used to estimate
the dissociation constant, Kd, of morin
and myricetin despite the uncertainty in the actual concentration
of the ligands available in solution due to their precipitation. As
the exchange is rapid on the chemical shift timescale, an estimated Kd value of around 300 μM for the two ligands
(Supporting Information Table S4 and Figure S11) could be calculated using the residues with the highest CSPs (L65
and D66). To determine the influence of Zn(II) on flavonol interactions,
the CSPs of the NDM-1 backbone resonances were followed using the 1H–15N HSQC spectra recorded at each flavonol
increment in the absence of Zn(II) (Figure b and Supporting Information Figure S12). As for the flavonol titrations performed
in the presence of Zn(II) (Figure a), we verified that the addition of DMSO did not induce
significant variations in the chemical shift of the NDM-1 resonances
in the absence of zinc (Supporting Information Figure S12).The analysis shows that flavonols also
interact with NDM-1, but
the CSPs are lower at equal ligand concentration and more dispersed
along the protein sequence compared to what happens in the presence
of 2 molar equiv of Zn(II). In the absence of Zn(II) and in the presence
of 2 (Figure b1) and
4 molar equiv (Figure b2) of morin, for example, the ASL1 and ASL4 loops are the domains
of NDM-1 that undergo the major CSPs. However, in the absence of Zn(II),
several other regions are also targeted by the flavonols, including
residues 100–111, 135–138, and 156–177, compared
to that happened in the presence of Zn(II) (Figure a3). It is interesting to note that the two
tryptophan residues (W104 and W168) and the many localized hydrophobic
residues in these domains could interact with the highly hydrophobic
flavonols. Thus, the two Zn(II) ions contributed to increase the selectivity
of the interaction of NDM-1 for flavonols.Our results indicate
that morin, quercetin, and myricetin interact
with NDM-1 residues at the active site, without ejection of Zn(II).
Despite some chemical shift variations upon ligand binding, the 1H–15N HSQC spectra retain their initial
appearance, namely, the appearance of the NDM-1 spectrum in the presence
of 2 molar equiv of Zn(II), and not the NDM-1 spectrum recorded in
the absence of Zn(II). In addition, the hydrophobic residues around
the active site L65, F70, and W93 also appear to play an important
role in substrate recognition.Altogether, the residues L65,
M67, F70, W93, H122, Q123, D124,
N220, and H250 and the two Zn(II) are involved in the binding of flavonols.
Our NMR data demonstrated the specific interaction of morin, quercetin,
and myricetin at the NDM-1 active site.These results are in
agreement with the previous in silico modeling
and docking with the generated NDM-1 models, from an alignment with
two templates VIM-2 and VIM-4 by Ganugapati et al.[73] and the crystal structure of NDM-1 (PDB: 3SPU) by Padmavathi et
al.[74] The results of these two studies
indicated that quercetin may be the best inhibitor among the flavonoids
present in green tea (flavan-3-ols, flavones, and flavonols) tested
during dockings, in terms of energy values for the first study,[73] and calculated binding affinity after docking
for the second study.[74]
Reconstruction
of the NDM-1/Flavonol Binding Interfaces by Molecular
Docking Simulations
As no intermolecular NOE was observed
in the 15N–13C filtered 1H–1H NOESYs recorded on 13C–15N-labeled
NDM-1/flavonol complexes, the structural models of the NDM-1/morin,
NDM-1/quercetin, and NDM-1/myricetin complexes were constructed using
molecular docking simulations in the NMR data-driven program HADDOCK
(High Ambiguity Driven biomolecular DOCKing)[75] on the basis of experimental CSPs. To propose relevant models, several
series of calculation were undertaken using 19 crystallographic structures
of NDM-1 as the docking results may be influenced by the starting
protein structure,[76] whether obtained in
the presence or absence of ligand. Ten of them were complexed with
a ligand and were used after removal of the complexed ligand, and
we called them “artificial” NDM-1 crystal structures
(art-apo NDM-1). Five structures were apo NDM-1 crystal structures
(crystallized in the absence of ligand), and four were metal-free
apo forms of NDM-1 (crystallized in the absence of ligand and in the
absence of Zn(II)). The superimposition on the backbone atoms (domain
45–270) of the 10 art-apo NDM-1 structures with each other
and with the five apo NDM-1 structures highlights that the main structural
differences between all of these structures are located in the loops
ASL1 and ASL4 (Supporting Information Figure S13). Furthermore, the distances between the two Zn(II) (Zn1 and Zn2)
fluctuate from one structure to the other depending on the presence
or absence of a ligand and also of the type of ligand, with the Zn1–Zn2
distances varying from 3.1 to 3.8 Å in the five apo NDM-1 crystal
structures, and from 3.6 to 4.6 Å in the 10 art-apo NDM-1 structures
used for our docking. In fact, it has been shown by Zhang et al.[77] that Zn1–Zn2 distance in the active site
of the native protein is affected by crystal packing, pH, and buffer
components. Although the Zn1–Zn2 distances in the enzyme/product
complexes are mostly at 4.6 Å,[77] this
distance is smaller in several other NDM-1 complexes (Supporting Information Table S5).Based on our experimental NMR
CSP values, the residues L65, M67, F70, W93, H122, Q123, D124, N220,
and H250 (Supporting Information Figure S13d,e) were determined to belong to the interface and used as ambiguous
interaction restraints in docking calculation with morin, which induced
the largest CSPs (Figure ) in the NDM-1 spectra. As the NDM-1 CSPs could be the result
of direct interactions with flavonol or/and the result of conformation
changes of the flexible loops, NDM-1 L65, M67, F70, W93, H122, Q123,
D124, N220, and H250 residues were defined as “passive”
residues and flavonol as an “active” residue (as defined
in the HADDOCK software) in a first step. The best generated models,
selected on the basis of the HADDOCK score (Supporting Information Table S6), using the four metal-free apo (Supporting
Information Figure S14 and Table S6), the
five apo (Supporting Information Figure S15 and Table S6), or the 10 art-apo NDM-1 structures (Supporting Information Figure S16 and Table S6), show that the morin
is located in the substrate-binding pocket and is able to contact
the Zn(II) ions via polar contacts.The flavonols are recognized
as metal-ion chelators;[78−82] they bind to Zn(II) ions[82] with a lower
affinity than NDM-1 does.[23,24] A binding association
constant of 3.57 ± 0.1 × 104 M–1 was found between quercetin and Zn(II) in protein-free solution
by Bhuiya et al.[82] A flavonol molecule
has three potential sites for cation chelation: (i) the 3′,4′
or 2′,4′-dihydroxy group or 3′,4′,5′-trihydroxy
group located on the B-ring (depending on the type of flavonol); (ii)
between the 3-hydroxy and the 4-carbonyl groups in the C-ring; (iii)
and via the 5-hydroxy and the 4-carbonyl group (Figure b). In addition, we determined by NMR that
the Zn(II) ions direct flavonols binding to the active site of NDM-1
(Figure ). All of
these data showed that both Zn(II) ions probably play a role in the
coordination of flavonols at the NDM-1 binding site. Therefore, in
the second step of docking simulations, both Zn(II) were defined as
active residues in addition to the L65, M67, F70, W93, H122, Q123,
D124, N220, H250, and NDM-1 residues defined as passive residues and
morin as an active residue using again the five apo (Supporting Information Figure S17 and Table S7) and the 10 art-apo NDM-1
crystallographic structures (Supporting Information Figure S18 and Table S7).Analysis of the four best
structures of each top clusters shows
that, as expected, the morin targets the Zn(II) ions through polar
contacts. The orientation of the morin in the active site of NDM-1
was strongly dependent on the crystallographic structure used for
docking (Supporting Information Figures S17–S18). Either the morin adopts only a single orientation in the NDM-1
active site for the four structures in each top cluster or the orientations
are very different from each other. In the first case, the rmsd values
calculated on the morin atoms after superimposition on the (45–271)
backbone atoms of the NDM-1 structures (art-apo PDB: 4EY2, 4EYB, 4HL2, 4RL0, 4EYF) are between 0.68
and 1.43 Å, and in the second case, (art-apo PDB: 4EXS, 4EYL, 4RAM, 4RBS, 4RL2) between 2.58 and
5.40 Å (Supporting Information Table S8). It is interesting to note that this difference in behavior seems
to be related to the Zn1–Zn2 distances in the starting structures
of NDM-1 used for the docking since they vary from 4.5 to 4.6 Å
in the first case and from 3.1 to 4.1 Å in the second case (Supporting
Information Table S5) and also to the orientation
of the ASL1 loop toward the active site (Supporting Information Figure S13c). A 62.5% of the structures analyzed
adopt orientation 1 (Figure a,c) with an average rmsd of 0.91 ± 0.32 Å for 52.5%
of them and 3.24 ± 0.59 Å for the remaining. A 17.5% of
the structures are in orientation 2 (Figure b,d) with a main rmsd value of 3.35 ±
1.09 Å between them. We observed a loss of Zn2 coordination in
the remaining structures (20%), so we did not associate them to any
group. It is interesting to note that the loss of Zn2 coordination
is only observed for the NDM-1 starting structures with the shortest
Zn1–Zn2 distances. More precisely, the Zn1–Zn2 distance
is the factor that most strongly affected the positioning of the ligand
in the active site during molecular docking simulations. As already
described by Zhang et al.,[77] although the
Zn1–Zn2 distances observed in different structures of NDM-1
complexed with hydrolyzed antibiotics are longer than those observed
for NDM-1 in the native form, they fluctuate after all between 3.8
and 4.6 Å and are also highly dependent on the type of ligand.
Therefore, the choice of NDM-1 starting structures for docking with
ligands capable of binding Zn(II) strongly influences the final results.
Our docking results show that the PDB crystal structures 4EY2, 4EYB, 4HL2, and 4EYF are the most suitable
for docking calculations with the morin structure. Indeed, the smallest
deviations of Zn1 and Zn2 after docking from their positions in the
original crystal structures were observed with these four crystal
structures (Supporting Information Figure S19). These structures have the largest distances between Zn1 and Zn2,
4.6 Å (Supporting Information Table S5). In addition, the rmsd values calculated on the morin atoms are
also the lowest (Supporting Information Figure S18 and Table S8).
Figure 8
Models of the NDM-1/morin complexes generated
using HADDOCK. (a)
Superimposition of 21 structures over the 40 structures clustered
in the top clusters, generated using the 10 art-apo NDM-1 crystallographic
structures (PDB: 4EXS, 4EY2, 4EYB, 4EYF, 4EYL, 4HL2, 4RAM, 4RBS, 4RL2, 4RL0) showing the predominant
orientation of morin at the active site of NDM-1 (orientation 1).
These 21 structures adopt two slightly different orientations in the
active site, 11 are in dark pink, and 10 in light pink. (b). A minority
orientation is also observed in the docking generated structures (orientation
2). Orientation 2 differs from orientation 1 by a rotation of about
180°. (c) Zoom on one of the 21 structures in which morin adopts
orientation 1 showing the polar contacts between the ligand and Zn(II)
ions (PDB: 4HL2) (cluster 1: structure 2). (d) Zoom on one of the structures in
which morin adopts orientation 2 showing the polar contacts between
the ligand and Zn(II) ions (PDB: 4RBS (cluster 1: structure 1)). The Zn(II)
ligands are represented by stick and colored yellow, Zn1 is orange,
and Zn2 is green and represented by spheres. L65, M67, F70, W93, Q123,
and N220, defined as active residues (in addition to H122, D124, and
H250 in yellow) upon docking are represented by stick and colored
differently for better identification.
Models of the NDM-1/morin complexes generated
using HADDOCK. (a)
Superimposition of 21 structures over the 40 structures clustered
in the top clusters, generated using the 10 art-apo NDM-1 crystallographic
structures (PDB: 4EXS, 4EY2, 4EYB, 4EYF, 4EYL, 4HL2, 4RAM, 4RBS, 4RL2, 4RL0) showing the predominant
orientation of morin at the active site of NDM-1 (orientation 1).
These 21 structures adopt two slightly different orientations in the
active site, 11 are in dark pink, and 10 in light pink. (b). A minority
orientation is also observed in the docking generated structures (orientation
2). Orientation 2 differs from orientation 1 by a rotation of about
180°. (c) Zoom on one of the 21 structures in which morin adopts
orientation 1 showing the polar contacts between the ligand and Zn(II)
ions (PDB: 4HL2) (cluster 1: structure 2). (d) Zoom on one of the structures in
which morin adopts orientation 2 showing the polar contacts between
the ligand and Zn(II) ions (PDB: 4RBS (cluster 1: structure 1)). The Zn(II)
ligands are represented by stick and colored yellow, Zn1 is orange,
and Zn2 is green and represented by spheres. L65, M67, F70, W93, Q123,
and N220, defined as active residues (in addition to H122, D124, and
H250 in yellow) upon docking are represented by stick and colored
differently for better identification.In orientation 1 and orientation 2, electrostatic interactions
are observed between Zn2 and O-3 (cycle C), O-4 (cycle C), and O-5
(cycle A). Zn1 is either targeted by 5-O (cycle A) in orientation
1 or by O-3 (cycle C) in orientation 2 (Figure c,d). In addition, hydrogen-bond interactions
are also observed between O-7 (cycle A) and the amide proton of Q123
and between O-2′ (cycle B) and the amide proton of N220 in
orientation 1 in several complexes (Figure c). Morin also showed a H-bonding with H189
in orientation 1 (Figure c). In addition, the three-ring system forms extensive nonpolar
interactions with L65, M67, F70, and W93 (Figure ). Moreover, the CSPs observed for several
Zn(II) ligands such as H122, D124, and H250, and to a lesser extent
C208, could be explained by a slight movement of Zn1 and Zn2 and their
ligands during the interaction between NDM-1 and flavonols, as well
as a direct interaction with flavonols (Figure ).To investigate whether the number
and position of hydroxy groups
on the B-ring could influence the orientations of flavonol in the
active site of NDM-1, docking simulations were also undertaken using
quercetin (Supporting Information Table S9) and myricetin (Supporting Information Table S10) using the protocol already described in the previous paragraph.
The molecular docking results show that morin, quercetin, and myricetin
are located in the same binding site (Supporting Information Figure S20). The variability of ligand orientations
in the active site of NDM-1 is greater for quercetin and myricetin
than for morin and the number of structures rejected (usually due
to loss of Zn2 coordination (Supporting Information Figure S18)) is also greater for quercetin and myricetin than
for morin. Quercetin and myricetin also predominantly adopt orientation
1. In orientation 1 and orientation 2, the Zn(II) ions/morin, Zn(II)
ions/quercetin, and Zn(II) ions/myricetin interactions are quite similar
regardless of flavonol.It is interesting to note that the addition
of methoxy groups at
the 3′, 5, or 3 positions slightly decrease the inhibition
of native quercetin (Figure d). We verified using molecular docking simulation that the
three quercetin derivatives are still able to interact with Zn(II)
(Supporting Information Figure S21) with
approximately the same structural statistics (Table S11) as quercetin wild type. As for quercetin, orientation
1 is mainly adopted by quercetin derivatives. In all cases, their
C4 carbonyl group interacts with Zn2 in the active site of NDM-1.
Moreover, despite the possible steric hindrance generated by the replacement
of the hydroxyl group by a methoxy at positions 3 (MG194c2) or 5 (MG188c)
(Figure d), the structures
resulting from docking show that these two quercetin derivatives are
still capable of complexing Zn1 by their 5-O (cycle A). This is also
true for the derivative in which the hydroxyl group has been replaced
by a methoxy at the 3′ position (MG187c). The slight decreases
in inhibition are explained by the steric hindrance generated by the
methoxy groups.There are very few flavonol structures that
interact with metal
ions within a protein. Interestingly, quercetin has been shown to
have strong inhibitory activities against yeast alcohol dehydrogenase,
which has been explained on the basis of the formation of a complex
between quercetin and the Zn(II) ion that maintains the tertiary structure
of the metallo-enzyme.[7,82] In addition, the crystal structures
of quercetin 2,3-dioxygenase, a mononuclear copper-dependent dioxygenase
(PDB: 1H1I, 1H1M),[83] and quercetin 2,4-dioxygenases, which uses nickel as an
active site cofactor to catalyze oxidative cleavage, complexed with
the quercetin substrate (PDB: 5FLI),[84] show that
the coordination of the metal ions involved in both cases, the 3-hydroxy
and the 4-carbonyl groups in the C-ring of quercetin with distances
around 2.3 and 3.5 Å, respectively. We also observed in orientation
1 and orientation 2 of our NDM-1/flavonol models the electrostatic
interactions between Zn2 and the 3-hydroxy and the 4-carbonyl groups
of quercetin.NDM-1 hydrolyzed antibiotics such as methicillin
(PDB: 4EY2),
oxacillin (PDB: 4EYB), meropenems (PDB: 4RBS, 4EYL), benzylpenicillin
(PDB: 4EYF),
cephalosporins (PDB: 4RL2, 4RL0), penicillin
G (PDB: 4RAM), and ampicillin (PDB: 4HL2) bind the two Zn(II) through polar interaction with
the carbapenem C3 and C6 carboxylate oxygens (Supporting Information Figure S22). Most of MBL inhibitors belong to
one of two categories: either they act by sequestration of Zn(II),
such as EDTA[17,47,85,86] and aspergillomarasmine A,[87] resulting in inactivation of the enzyme, or they have several
electron donor groups, such as carboxylate, carboxyl, thiol, and/or
nitrogen, which are capable of binding one or both Zn(II) in the active
site[17,27−31,33−44,50,88−91] to act as competitive inhibitors. We show that flavonols belong
here to the second category and that they are able to bind to both
Zn(II) in the active site of NDM-1, without expelling the Zn(II) ions
from the protein.
Conclusions
Our analysis of NDM-1
by NMR in the absence and presence of Zn(II)
shows that specific regions (ASL2, ASL3, ASL5, and L9 loops and Helix
α2) of the protein were affected by the binding of two Zn(II).
Ion binding led to the rigidification of the protein with respect
to the metal-free NDM-1, but the ASL1 loop retained its slight flexibility
even after Zn(II) binding. Our assay of inhibitor activities and structural
characterization of NDM-1/flavonols complexes in the presence of Zn(II)
show that morin, myricetin, and quercetin interact in the same binding
site as antibiotics and that these interactions are largely driven
by the interaction with both Zn(II) as is the case for substrate recognition
in MBLs, which is largely determined by the interaction with metal
ions.[92,93]
Experimental Section
Protein Production and
Purification
The gene sequence
encoding the NDM-1 mature enzyme from G29 to R270 was subcloned into
a pET41b vector with a C-terminal His6 tag to facilitate protein purification.
For the overexpression of the double 15N/13C/-labeled
NDM-1 sample, the fusion protein was expressed in BL21 E. coli cells. A 100 mL Lysogeny broth (LB) culture
supplemented with 40 μg/mL kanamycin was inoculated with 10
mL of a fresh overnight LB preculture and grown at 37 °C until
OD600 = 1.5. After a 10 min centrifugation at 5000 rpm,
the bacterial pellet was resuspended in 1 L of M9 minimal medium (Na2HPO4, 6 g/L; KH2PO4, 3 g/L;
NaCl, 0.5 g/L; MgSO4, 1 mM; CaCl2, 1.10–4 M) containing 2.0 g/L [13C]glucose, 1
g/L [15N]NH4Cl, and 40 μg/mL kanamycin
preincubated at 37 °C. The culture was maintained in this medium
at 37 °C until OD600 ∼ 0.6. Subsequently, induction
with 0.4 mM isopropyl-β-d-thiogalacto-pyranoside took
place for 20 h at 28 °C.The bacteria were spun down at
5000 rpm for 10 min, and the pellet (3.5 g) was washed in phosphate-buffered
saline (PBS); sonicated 15 times with 10 s pulses at 4 °C in
30 mL of buffer A (20 mM sodium phosphate pH 7.5, 0.5 M NaCl, 10 mM
imidazole, 1 mM β-ME) containing 0.5 mg/mL lysosyme, 100 μg/mL
DNase, and one tablet of complete mini EDTA-free protease inhibitor
cocktail (Roche Diagnostics); and centrifuged (100 000g for 30 min). The supernatant was applied two times on
a 1 mL His GraviTrap affinity column (GE Healthcare) equilibrated
with buffer A, and the column was washed with 20 mL of buffer A containing
20 mM imidazole. Then, elution of the protein was carried out in buffer
A containing 0.3 M imidazole. The eluted fraction containing pure
NDM-1 (about 50 mg) was brought to a concentration of 500 μM
by ultrafiltration and dialysis against 0.1 M Bis-Tris-HCl pH 7.0.
Thermal Shift Assay
The thermal shift assay was performed
using the ABI7900HT Real-Time PCR system (Applied Biosystems). The
assay quantifies the binding of the Sypro Orange probe to exposed
hydrophobic regions of proteins challenged to a temperature gradient.[94] The dye becomes highly fluorescent when bound
to protein hydrophobic sites. NDM-1 samples (9 μM) were incubated
in buffer 100 mM Bis-Tris pH 7 containing different ZnCl2 concentrations and Sypro Orange (650-fold diluted from stock solution;
Invitrogen). Reactions were carried out in duplicate in a 96-well
fast PCR plate at a final volume of 20 μL. The samples were
submitted to denaturation from 15 to 95 °C at a rate of 3 °C/min,
and fluorescence of Sypro Orange dye was recorded in real time (excitation
spectra, 488 nm; emission spectra, 500–650 nm). The protein
denaturation temperature was calculated using the software SDS2.4.1
as the maximum of the derivative of the resulting fluorescence curves.
Enzyme Activity Assay Screening Library
All of the
compounds tested as potential inhibitors of NDM-1 were either purchased
from Sigma-Aldrich Corporation or available from LabEx LERMIT. The
CAS numbers are as follows: hydroxybenzophenone (CAS 68751-90-6),
2-hydroxybenzophenone (CAS 117-99-7), 2′,4′-dihydroxy-3′-methylpropiophenone
(CAS 63876-46-0), 5-hydroxy-p-naphthoquinone (CAS
481-39-0), 4-chromanone (CAS 491-37-2), quercetin (CAS 117-39-5),
myricetin (CAS 529-44-2) and morin (CAS 654055-01-3), rutin (CAS 207671-50-9),
eriodictyiol (CAS 4049-38-1), taxifolin (CAS 480-18-2), naringenin
(CAS 67604-48-2), and dihydromyricetin (CAS 27200-12-0). They were
dissolved in 100% DMSO as 5 or 10 mM stock solutions. The imipenem
antibiotic was purchased from Ranbaxy and dissolved in Milli-Q water
as a 10 mM stock solution. To determine the percentage of inhibition,
a miniaturized automated assay was set up based on a 96-well plate
format with a concentration of 0.5 μg/mL NDM-1. The screening
assay conditions were as follows: 100 mM phosphate buffer, pH 7.0
(Na2HPO4/NaH2PO4) added
with 50 μM ZnSO4; 100 μM imipenem, and 50 μM
of compound (dissolved in DMSO) monitored by a Varian Cary 300 Bio
UV–Visible spectrophotometer at 297 nm; time course, 600 s;
25 °C. Imipenem was added into the reaction after 5 min of incubation.
In parallel, two controls were performed: positive control was performed
with DMSO instead of compound and the negative control with 1 mM EDTA.
The equation for the calculation of the percentage of inhibition is:
Percentage inhibition = (1 – (I0 – IEDTA)/(IDMSO – IEDTA)) x 100%, where I0 is the intensity of the product signal in
each well, IEDTA is the intensity in the presence of EDTA, and IDMSO
is the intensity in the presence of DMSO.
IC50 Determination
IC50 of the
inhibitors was determined in 100 mM phosphate buffer, pH 7.0 (Na2HPO4/NaH2PO4), added with
50 μM ZnSO4 and 100 μM imipenem, and the mixture
was incubated for 3 min. The assay was performed with an ULTROSPEC
2000 UV spectrophotometer and SWIFT II software (GE Healthcare, Velizy-Villacoublay,
France). IC50 values were obtained using the equation IC50 = ((1/0.5 × v0) – m)/q, where v0 is the rate of hydrolysis of the reporter substrate (v0 being the rate measured in the absence of inhibitor), q is the y axis intercept, and m is the slope of the resulting linear regression.
MIC values were
determined by broth microdilution, in triplicate,
in cation-adjusted Mueller Hinton broth according to the Clinical
Laboratory Standards Institute (CLSI) guidelines. Two enterobacterial
clinical strains expressing the carbapenemase NDM-1 were used: E. coliNDM-1 GUE and K. pneumoniaeNDM-1 CAG. Experiments were performed in microtiter plates containing
the medium with imipenem and inhibitors (myricetin and quercetin)
dissolved (DMSO) at different concentrations (0.5, 5, 50, 500, and
1000 μM). Plates were incubated overnight at 37 °C for
18–24 h.
NMR Backbone Resonance Assignment
Samples for NMR spectroscopy
are composed either of 0.1 M Bis-Tris-HCl pH 7.0 buffer, supplemented
by 150 mM NaCl or 50 mM phosphate sodium pH 6.5 depending, respectively,
on the presence or absence or of ZnCl2 in the solutions,
and 95%/5% H2O/D2O. Protein concentration was
set from 100 to 996 μM. The NMR spectra were recorded on 600
and 800 MHz Bruker Avance III spectrometers at different temperatures
ranging from 20 to 35 °C depending on the presence or absence
of ZnCl2. The two spectrometers are equipped with a 5 mm z-gradient TCI (H/C/N) cryoprobe.The backbone resonance
assignments were performed in the absence or presence of ZnCl2 using the standard triple resonance experiments: HNCA, HN(CO)CA,
HNCO, HN(CA)CO, HNCACB, and HN(CO)CACB. 3D NOESY-15N edited
spectra (mixing times 100 and 200 ms) were also collected to help
the assignment. NMR data were processed using TOPSPIN 3.5 software
(Bruker) and analyzed using CcpNmr 2.4.2 software (http://www.ccpn.ac.uk).[95] NDM-1 resonance assignments in the absence and
presence of 2 molar equiv of Zn(II) were deposited in BMRB accession
numbers 26950 and 26952, respectively.
15N Relaxation
Measurements
The 15N R1 and R2 relaxation rates and {1H}–15N heteronuclear
NOE were measured at 25 °C and 600 MHz 1H frequency
on the metal-free NDM-1 and di-Zn(II)NDM-1 complex. The experiments
were based on the TROSY-based relaxation experiments[96] and recorded in an interleaved pseudo-3D method. For the
determination of R1 relaxation constants,
13 total data sets were collected at relaxation delay times of 20
(duplicated), 100, 200, 300, 500, 600, 750, 900, 1000, 1200, 1400,
and 1700 ms. For the determination of R2 relaxation constants, 13 data sets were collected at delay times
of 16.96 (duplicated), 33.92, 50.88, 67.84, 101.76, 118.72, 152.64,
169.60, 203.52, 237.44, 271.36, and 305.28 ms.Two two-dimensional
(2D) 1H–15N planes were collected in
the presence or absence of a 3 s 1H saturation sequence
(120° 1H pulses train) during relaxation delay to
extract the {1H}–15N heteronuclear NOE.
Spectral widths were 1.630 and 4.208 kHz along the 15N
and 1H dimensions, respectively, and the interscan delay
was set to 5 s. The acquisition times were 121.65 and 41.5 ms in the 1H and 15N dimensions, respectively, with 16 scans
per increment for the determination of R1 and R2 relaxation constants. The duration
of the experiments was around 2 days each. For {1H}–15N heteronuclear NOE experiments, the acquisition times were
121.65 and 62.3 ms in the 1H and 15N dimensions,
respectively, with 32 scans per increment and a duration of experience
of 14 h.
NMR HSQC Titration Experiments
The NDM-1–Zn(II)
interaction was characterized by means of chemical shift perturbations
(CSPs), using a series of 1H–15N HSQC
experiments recorded upon the addition of increasing concentration
of ZnCl2. The protein, concentrated to 320 μM, was
solubilized in 0.1 mM Bis-Tris solution, pH 7, supplemented by 150
mM NaCl. ZnCl2 was dissolved in 0.1 mM Bis-tris buffer,
pH 7, to a concentration of 20 mM in the stock solution.The
flavonols (morin, quercetin, and myricetin) interaction surfaces on
NDM-1 were characterized in the presence of 2 molar equiv of Zn(II).
The flavonols were dissolved in 100% DMSO at a concentration of 20
mM. We titrated 320 μM of NDM-1 with the flavonols (0–4
molar equiv for morin, 0–3 molar equiv for myricetin, and 0–2
molar equiv for quercetin). Approximately 2.7 μL of DMSO was
added by an equivalent of flavonol (the final concentration of DMSO-d6 did not exceed 5% in the NMR tube), and at
each stage of the titration, one-dimensional (1D) 1H and
2D 1H–15N HSQC spectra were recorded.
In all cases, we observed a slight precipitation of the ligands probably
due to their hydrophobic properties. Each HSQC spectrum was collected
with eight scans per increment with spectral widths of 9.6 and 3.2
kHz for 1H and 15N, respectively, as well as
256 data points in the indirect dimension. The experiments used the
3-9-19 watergate sequence[97] for water suppression.
The weighted chemical shift change of each NH signal was calculated
according to:Δδ (1H, 15N)
= [((ΔδH)2 + (ΔδN)2 ×
0.14) × 0.5]1/2, where δH and δN are the modifications of the chemical shift in the 1H and 15N dimensions, respectively.[98]
NDM-1/Flavonol Dockings Using HADDOCK
Ambiguous distance
restraints based on chemical shift perturbations were used to drive
the docking between NDM-1 and the three flavonols: morin, quercetin,
and myricetin. Nineteen crystallographic structures of NDM-1 were
used: (i) 10 of them were in complex with a ligand: hydrolyzed methicillin
(PDB: 4EY2),
hydrolyzed oxacillin (PDB: 4EYB), l-captopril (PDB: 4EXS); hydrolyzed meropenems
(PDB: 4EYL, 4RBS); hydrolyzed benzylpenicillin
(PDB: 4EYF);
hydrolyzed cephalosporins (PDB: 4RL0, 4RL2), hydrolyzed penicillin G (PDB: 4RAM), hydrolyzed ampicillin
(PDB: 4HL2),
these structures were used after removing of the ligand localized
in the active site of the NDM-1 crystallographic structures, and named
“artificial apo” (art-apo) NDM-1 structures; (ii) five
of them were apo NDM-1 crystal structures (PDB: 4TYF, 3S0Z, 4TZF, 4TZE, 3SPU); (iii) four were
metal-free apo form of NDM-1 (PDB: 3RKJ, 3RKK, 3SBL, 3PG4). The three flavonol structures were
extracted from crystal structures: morin PDB: 6AE3, 5AUY; quercetin PDB: 2UXH; myricetin PDB: 2O63 where they were
in complex with proteins. The L65, M67, F70, W93, H122, Q123, D124,
N220, and H250 residues were defined as belonging to the NDM-1 interaction
surface with the flavonols. In a first series of calculations, the
two Zn(II) were defined as passive residues and in a second series
as active residues. In addition, a restraint file (unambiguous restraints)
that imposed the distances between Zn1 and Zn2, on the one hand, and
between Zn1 and Zn2, and their respective ligands His120, His122,
His189 and Asp124, Cys208, His250, was supplied to HADDOCK[75] to maintain the geometry around each Zn(II).
For the two series of calculations, L65, M67, F70, W93, Q123, N220,
D124, and H250 were defined as passive residues. In all of the steps,
the residues belonging to the segments 65, 92–94, 123, and
218–222 were defined as fully flexible segments, and those
belonging to 66–73 as semiflexible segments. During the rigid-body
docking, 2000 structures were calculated, and 400 or 200 (depending
on the calculation) during both simulated annealing and water refinement.
All 400 or 200 water-refined structures were analyzed, and the cutoff
for clustering was 7.5, or 0.6 Å for interface RMSD or Fraction
of Common Contacts (FCC) respectively, with four structures per cluster.
The ranking of the clusters is based on the average score of the top
four members of each cluster. The HADDOCK score is calculated as a
function of the intermolecular van der Waals energy, intermolecular
electrostatic energy, empirical desolvation energy term, and ambiguous
interaction restraints (AIRs) energy. The cluster numbering reflects
the size of the cluster, with cluster 1 being the most populated cluster.
After successful docking, the best complex models were selected on
the basis of the HADDOCK score (Tables S6, S7, S9, and S10). The same protocol was used for the docking of
NDM-1 (PDB: 4EY2) and three quercetin conjugates: quercetin-CH3A (quercetin with
OMe in position 5); quercetin-CH3B (quercetin with OMe in position
3′); and quercetin-CH3C (quercetin with OMe in position 3)
(Table S11).
Authors: Alexander Bergstrom; Andrew Katko; Zach Adkins; Jessica Hill; Zishuo Cheng; Mia Burnett; Hao Yang; Mahesh Aitha; M Rachel Mehaffey; Jennifer S Brodbelt; Kamaleddin H M E Tehrani; Nathaniel I Martin; Robert A Bonomo; Richard C Page; David L Tierney; Walter Fast; Gerard D Wright; Michael W Crowder Journal: ACS Infect Dis Date: 2017-11-09 Impact factor: 5.084
Authors: Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford Journal: Lancet Infect Dis Date: 2010-08-10 Impact factor: 25.071
Authors: Victoria L Green; Anil Verma; Raymond J Owens; Simon E V Phillips; Stephen B Carr Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun Date: 2011-09-06
Authors: Yuejuan Zhang; Cheng Chen; Bin Cheng; Lei Gao; Chuan Qin; Lixia Zhang; Xu Zhang; Jun Wang; Yi Wan Journal: Front Pharmacol Date: 2022-06-22 Impact factor: 5.988
Authors: Faizah S Aljohani; Nadjet Rezki; Mohamed R Aouad; Mohamed Hagar; Basant A Bakr; Marwa M Shaaban; Bassma H Elwakil Journal: Antibiotics (Basel) Date: 2022-07-07